Video: Rare Disease Report interview with Sarepta Therapeutics – an exciting time for the rare disease community
Our media partner, Rare Disease Report, spoke with Chris Garabedian, CEO of Sarepta Therapeutics, on why it’s an exciting time for the rare disease community and orphan drug sector.
Check out the first video below:
Additionally, Chris gave a sneak preview on his upcoming presentation, ‘Leveraging a personalized medicine platform to treat genetic sub-groups.’ View this preview in the second video clip, below:
Chris will be speaking at the upcoming World Orphan Drug Congress USA on this topic. Download the brochure for more information.
